Affiliate Article:
Off-Label Information Dissemination, Safe Harbor, and MSLs
Author: Jane Chin, Ph.D., President, Medical Science Liaison Institute, LLC


This article discusses the often misinterpreted “safe harbor” and whether MSLs enjoy such protection when disseminating off-label information. Where, if anywhere, does the law ascribe “safe harbor” surrounding verbal and written dissemination of off-label use for a drug? Ironically, the term “safe harbor” is not found in FDAMA document. If a pharmaceutical employee works within the boundaries specified by what is collectively identified as “safe harbor,” the company is safe. If the employee’s actions fall outside the box, it is fair game. This does not mean it is illegal per se.

Topics covered include:

  • Deconstructing “Safe Harbor”
  • Compliance Programs are Useless Without Enforcement at Both the Corporate Level and Field Level
  • Effective Compliance Requires Leadership, Not Lip-Service
  • Helpful Links to more information

Order this article and learn more … $24.95
(Pay online by credit card. 5-page PDF file delivered to you by email, usually within a few minutes)

Special Supplement
Physician Education
Key Opinion Leaders, Medical Science Liaisons, & CME
A New Addition to the Pharma Marketing News Archives!

PhysEd Supplement Cover OVERVIEW

It’s a new era for pharmaceutical company support of physician education. New guidelines and regulations from various governmental and non-governmental regulatory bodies have come into play during the past few years. The second event defining this new era was the withdrawal of Vioxx from the market in 2004 and the subsequent re-emergence of the importance of physicians as “learned intermediaries.”

More than ever, it is important to educate physicians about new drugs and to keep this education separate from the marketing function of the company yet aligned with commercial goals.

This Special Supplement to Pharma Markeing News is critical reading for pharmaceutical companies and physician education service providers wishing to understand the new roles of key opinion leader physicians (KOLs) and medical science liaisons (MSLs) in the physician education process.


Order and pay for this Special Supplement now using your credit card

ONLY $29.95
PDF file delivered to you by email (usually within minutes of placing your order):

If you wish to be pay by check or credit card off-line, please use:
Printable Order Form